Cross-Site Scripting Vulnerability in IBM Engineering Lifecycle Optimization
CVE-2024-52890

6.1MEDIUM

Key Information:

Vendor

IBM
Status
IBM Engineering Lifecycle Optimization - Publishing
Vendor
CVE Published:
5 August 2025

What is CVE-2024-52890?

IBM Engineering Lifecycle Optimization - Publishing versions 7.0.2 and 7.0.3 are vulnerable to cross-site scripting attacks due to inadequate validation of URIs. This vulnerability may allow attackers to inject malicious scripts, compromising the integrity and security of users' sessions.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

IBM Engineering Lifecycle Optimization - Publishing 7.0.2

IBM Engineering Lifecycle Optimization - Publishing 7.0.3

References

https://www.ibm.com/support/pages/node/7241392
vendor-advisorypatch

CVSS V3.1

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.